Tag: HRS 2017
HRS 2017: New implantable string subcutaneous defibrillator shows promise for sudden...
The use of a novel implantable string subcutaneous defibrillator (ISSD, Newpace) that has no can, and has been designed to be placed without the...
HRS 2017: Could etripamil nasal spray be a “game-changer” for paroxysmal...
A phase 2 trial (NODE-1) of a nasal spray formulation of etripamil (Milestone Pharmaceuticals) shows it is safe and effective at terminating paroxysmal supraventricular...
HRS 2017: Watchman prevents stroke even in high-risk patients: One-year follow-up...
Left atrial appendage closure with the Watchman device (Boston Scientific) is safe and effective at stroke prevention, with a high implant and sealing success,...
HRS 2017: Endovascular occlusion balloon inclusion during lead extraction reduces mortality
Patients who suffer superior vena cava tears (SVC) during lead extraction are more likely to survive when treatment includes an endovascular occlusion balloon, a...
HRS 2017: S-ICDs successful despite a range of comorbidities, and across...
Initial real-world experience with the S-ICD (subcutaneous implantable cardioverter defibrillator) in the USA show that implant success rate is high and short-term complications acceptably...
HRS 2017: Long detection in single chamber ICDs cuts mortality and...
Unnecessary shocks and all-cause mortality are reduced in patients treated with a single chamber implantable cardioverter defibrillator (ICD) programmed with a long detection window.
Lead...
HRS 2017: True incidence of atrial fibrillation is underestimated
A substantial number of patients at risk for atrial fibrillation (AF) may remain undetected using conventional monitoring techniques, a late-breaking clinical trial session at...
HRS 2017: Micra reinforces its success in the real world
The Micra leadless pacemaker continues to demonstrate a high implant success rate and a low level of major complications at 30 days in a...
Boston Scientific announces scheduled presentations at Heart Rhythm Society 2017
Boston Scientific has announced the schedule of key data presentations, including two late-breaking clinical trials that will be featured at the Heart Rhythm Society’s...
Acutus Medical receives FDA clearance for AcQGuide Steerable Sheath
Acutus Medical has announced the FDA clearance of the AcQGuide Steerable Sheath, which marks the first US regulatory milestone for the company. The AcQGuide Steerable...
Thomas F Deering
Thomas F Deering (Piedmont Heart Institute, Atlanta, USA) considers that the biggest challenge in electrophysiology (EP) is to “move from the volume to the...